Janney Montgomery Scott
PVCT

Janney Montgomery Scott’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Janney Montgomery Scott’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$8.6K – 2348
2014
Q2 		$8.6K Buy
+10,000
New +$12K ﹤0.01% 2197

Other funds holding PVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Janney Montgomery Scott's PVCT Position: Q3 2014 in Review

Janney Montgomery Scott sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q3 2014, closing a stake of 10,000 shares — an estimated $8.6K sold.

Janney Montgomery Scott first reported a position in PVCT in Q2 2014 and held it in 1 quarter. The position peaked at $8.6K in Q2 2014. 30 funds tracked by Wall St. Rank hold PVCT as of Q3 2014.

  • Janney Montgomery Scott reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q3 2014 after selling out during the quarter.
  • Janney Montgomery Scott sold 10,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q3 2014, an estimated $8.6K.
  • Janney Montgomery Scott first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 1 quarter.
  • Janney Montgomery Scott's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $8.6K in Q2 2014.
  • 30 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q3 2014.

Based on Janney Montgomery Scott's 13F filing for Q3 2014, filed 14 Nov 2014.